Debra Patt, MD, PhD, MBA, MPH, discusses AI adoption, administrative burden, and strategies to streamline prior authorization in oncology.
|Articles|April 1, 2012
Dr. Dietrich Stephan Talks About Advancing the Field of Personalized Medicine
In this video, Dr. Stephan talks about key components to advancing the field of personalized medicine and also discusses the opportunities that lay ahead for the private sector.
Advertisement
In this video, Dr. Stephan talks about key components to advancing the field of personalized medicine and also discusses the opportunities that lay ahead for the private sector.
This video was taken at the CBI Conference on Personalized Medicine on March 13, 2012, in Washington, DC.
Advertisement
Related to this article
Patient factors and access barriers are reshaping treatment sequencing and individualized care for relapsed multiple myeloma, Amandeep Godara, MBBS, said.
Christos Vaklavas, MD, discussed barriers limiting rural oncology access and challenges to adopting resource-intensive therapies.
Shiven B. Patel, MD, MBA, shares strategies for closing biomarker testing gaps, including for patients with non–small cell lung cancer.
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
2
Twice-Yearly CD19 Therapy Targets MG Root Cause: Richard Nowak, MD, MS
3
GLP-1 Receptor Agonists Cut Ascites, Mortality in MASH
4
Hepatitis A Vaccine Prevents 96% of Infections Given Before Exposure
5